REG - CVS Group plc - Transaction in Own Shares

CVSAnnouncement

08/12/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251208:nRSH6187Ka&default-theme=true

RNS Number : 6187K  CVS Group plc  08 December 2025

08 December 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 05 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").

 

 Date of purchase:                                    05/12/2025
 Aggregate number of Ordinary Shares purchased:       12,974
 Lowest price paid per share (GBp):                   1,200.00
 Highest price paid per share (GBp):                  1,214.00
 Volume weighted average price paid per share (GBp):  1,211.79

CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,961,055 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 70,961,055 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has
repurchased 779,728 Ordinary Shares in aggregate at a weighted average price
of 1,215.61 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.

 

Individual transactions:

 

 Number of                   Transaction price (GBp share)  Time of                 Transaction        Trading Venue

 Ordinary Shares purchased                                  transaction (UK Time)   reference number

 204                         1202                           05/12/2025 08:02:59     1345897338243595   XLON
 82                          1200                           05/12/2025 08:08:15     1345897338244424   XLON
 459                         1212                           05/12/2025 08:49:22     1345897338249263   XLON
 120                         1208                           05/12/2025 08:55:35     1345897338249854   XLON
 72                          1210                           05/12/2025 08:59:59     1345897338250281   XLON
 444                         1210                           05/12/2025 08:59:59     1345897338250285   XLON
 82                          1210                           05/12/2025 09:26:59     1345897338253361   XLON
 252                         1214                           05/12/2025 10:03:32     1345897338256451   XLON
 124                         1212                           05/12/2025 10:24:34     1345897338257876   XLON
 262                         1214                           05/12/2025 11:37:41     1345897338263129   XLON
 196                         1214                           05/12/2025 12:29:44     1345897338266064   XLON
 111                         1214                           05/12/2025 12:29:44     1345897338266067   XLON
 201                         1212                           05/12/2025 12:49:13     1345897338267042   XLON
 201                         1212                           05/12/2025 12:49:13     1345897338267048   XLON
 43                          1212                           05/12/2025 12:49:13     1345897338267049   XLON
 201                         1212                           05/12/2025 12:49:13     1345897338267050   XLON
 63                          1212                           05/12/2025 12:49:13     1345897338267051   XLON
 201                         1212                           05/12/2025 13:06:51     1345897338268072   XLON
 72                          1214                           05/12/2025 13:06:51     1345897338268069   XLON
 1180                        1212                           05/12/2025 13:06:51     1345897338268076   XLON
 201                         1212                           05/12/2025 13:06:51     1345897338268077   XLON
 263                         1212                           05/12/2025 13:06:51     1345897338268078   XLON
 15                          1212                           05/12/2025 13:06:51     1345897338268079   XLON
 146                         1212                           05/12/2025 13:25:57     1345897338268965   XLON
 186                         1212                           05/12/2025 13:25:57     1345897338268963   XLON
 6315                        1212                           05/12/2025 13:25:57     1345897338268969   XLON
 201                         1212                           05/12/2025 13:25:57     1345897338268976   XLON
 62                          1212                           05/12/2025 13:25:57     1345897338268977   XLON
 201                         1212                           05/12/2025 13:25:57     1345897338268978   XLON
 122                         1212                           05/12/2025 13:25:57     1345897338268980   XLON
 466                         1212                           05/12/2025 13:25:57     1345897338268981   XLON
 72                          1214                           05/12/2025 13:56:32     1345897338271298   XLON
 147                         1212                           05/12/2025 13:59:26     1345897338271706   XLON
 7                           1212                           05/12/2025 14:25:29     1345897338273806   XLON

 

Contacts

CVS Group
plc
via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)
 
           +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint
Broker)
                +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR)
 
                                   cvsg@camarco.co.uk

Ginny
Pulbrook
+44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia.  CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSUPGPPPUPAPWM



            Copyright 2019 Regulatory News Service, all rights reserved